T. Rowe Price Associates’s iShares MSCI ACWI ex US ETF ACWX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.15M Sell
104,400
-142,840
-58% -$10.1M ﹤0.01% 1293
2025
Q4
$16.6M Hold
247,240
﹤0.01% 1103
2025
Q3
$16.1M Hold
247,240
﹤0.01% 1107
2025
Q2
$15.1M Hold
247,240
﹤0.01% 1027
2025
Q1
$13.7M Hold
247,240
﹤0.01% 1043
2024
Q4
$12.9M Buy
247,240
+20,040
+9% +$1.1M ﹤0.01% 1096
2024
Q3
$13M Buy
227,200
+220,000
+3,056% +$12M ﹤0.01% 1094
2024
Q2
$383K Buy
+7,200
New +$384K ﹤0.01% 2301
2023
Q3
Sell
-179,500
Closed -$8.84M 2889
2023
Q2
$8.84M Buy
+179,500
New +$8.84M ﹤0.01% 1095
2017
Q4
Sell
-93,026
Closed -$4.5M 2563
2017
Q3
$4.5M Buy
+93,026
New +$4.39M ﹤0.01% 1453
2017
Q2
Sell
-134,293
Closed -$5.86M 2555
2017
Q1
$5.86M Buy
+134,293
New +$5.69M ﹤0.01% 1410

Other funds holding ACWX

T. Rowe Price Associates's ACWX Position: Q1 2026 in Review

T. Rowe Price Associates reduced its iShares MSCI ACWI ex US ETF (ACWX) stake by 58% in Q1 2026, selling an estimated $10.1M and leaving 104,400 shares worth $7.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

T. Rowe Price Associates first reported a position in ACWX in Q1 2017 and has held it in 11 quarters since. The position peaked at $16.6M in Q4 2025. 701 funds tracked by Wall St. Rank hold ACWX as of Q1 2026.

  • T. Rowe Price Associates held 104,400 shares of iShares MSCI ACWI ex US ETF worth $7.15M as of Q1 2026.
  • T. Rowe Price Associates sold 142,840 iShares MSCI ACWI ex US ETF shares in Q1 2026, an estimated $10.1M.
  • iShares MSCI ACWI ex US ETF made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1293 holding.
  • T. Rowe Price Associates first reported a position in iShares MSCI ACWI ex US ETF in Q1 2017 and has held it in 11 quarters since.
  • T. Rowe Price Associates's iShares MSCI ACWI ex US ETF position peaked at $16.6M in Q4 2025.
  • 701 funds tracked by Wall St. Rank held iShares MSCI ACWI ex US ETF as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.